These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11950339)

  • 1. Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6"-amino-6"-deoxy-galactosylceramides.
    Zhou XT; Forestier C; Goff RD; Li C; Teyton L; Bendelac A; Savage PB
    Org Lett; 2002 Apr; 4(8):1267-70. PubMed ID: 11950339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.
    Liu Y; Goff RD; Zhou D; Mattner J; Sullivan BA; Khurana A; Cantu C; Ravkov EV; Ibegbu CC; Altman JD; Teyton L; Bendelac A; Savage PB
    J Immunol Methods; 2006 May; 312(1-2):34-9. PubMed ID: 16647712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of diglycosylceramides and evaluation of their iNKT cell stimulatory properties.
    Liu Y; Deng S; Bai L; Freigang S; Mattner J; Teyton L; Bendelac A; Savage PB
    Bioorg Med Chem Lett; 2008 May; 18(10):3052-5. PubMed ID: 18206371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.
    Fujio M; Wu D; Garcia-Navarro R; Ho DD; Tsuji M; Wong CH
    J Am Chem Soc; 2006 Jul; 128(28):9022-3. PubMed ID: 16834361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical Control of Cytokine Production Using Photoswitchable Galactosylceramides.
    Hartrampf N; Seki T; Baumann A; Watson P; Vepřek NA; Hetzler BE; Hoffmann-Röder A; Tsuji M; Trauner D
    Chemistry; 2020 Apr; 26(20):4476-4479. PubMed ID: 31788876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of human CD1d with and without alpha-galactosylceramide.
    Koch M; Stronge VS; Shepherd D; Gadola SD; Mathew B; Ritter G; Fersht AR; Besra GS; Schmidt RR; Jones EY; Cerundolo V
    Nat Immunol; 2005 Aug; 6(8):819-26. PubMed ID: 16007090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000.
    Raju R; Castillo BF; Richardson SK; Thakur M; Severins R; Kronenberg M; Howell AR
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4122-5. PubMed ID: 19535248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramides.
    Xing GW; Wu D; Poles MA; Horowitz A; Tsuji M; Ho DD; Wong CH
    Bioorg Med Chem; 2005 Apr; 13(8):2907-16. PubMed ID: 15781400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
    J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells.
    Goff RD; Gao Y; Mattner J; Zhou D; Yin N; Cantu C; Teyton L; Bendelac A; Savage PB
    J Am Chem Soc; 2004 Oct; 126(42):13602-3. PubMed ID: 15493902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of NBD-alpha-galactosylceramide and its immunologic properties.
    Sakai T; Ehara H; Koezuka Y
    Org Lett; 1999 Aug; 1(3):359-61. PubMed ID: 10822576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.
    East JE; Kennedy AJ; Webb TJ
    Med Res Rev; 2014 Jan; 34(1):45-76. PubMed ID: 23239102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro evaluation of alpha-GalCer epimers.
    Trappeniers M; Goormans S; Van Beneden K; Decruy T; Linclau B; Al-Shamkhani A; Elliott T; Ottensmeier C; Werner JM; Elewaut D; Van Calenbergh S
    ChemMedChem; 2008 Jul; 3(7):1061-70. PubMed ID: 18418814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand.
    Park JJ; Lee JH; Ghosh SC; Bricard G; Venkataswamy MM; Porcelli SA; Chung SK
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3906-9. PubMed ID: 18586489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
    Lang GA; Maltsev SD; Besra GS; Lang ML
    Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulation.
    Blauvelt ML; Khalili M; Jaung W; Paulsen J; Anderson AC; Brian Wilson S; Howell AR
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6374-6. PubMed ID: 18993065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments.
    Lang GA; Illarionov PA; Glatman-Freedman A; Besra GS; Lang ML
    Int Immunol; 2005 Jul; 17(7):899-908. PubMed ID: 15967785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amide-Linked C4″-Saccharide Modification of KRN7000 Provides Potent Stimulation of Human Invariant NKT Cells and Anti-Tumor Immunity in a Humanized Mouse Model.
    Saavedra-Avila NA; Keshipeddy S; Guberman-Pfeffer MJ; Pérez-Gallegos A; Saini NK; Schäfer C; Carreño LJ; Gascón JA; Porcelli SA; Howell AR
    ACS Chem Biol; 2020 Dec; 15(12):3176-3186. PubMed ID: 33296161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a 2"-deoxy-β-GalCer.
    Thakur MS; Khurana A; Kronenberg M; Howell AR
    Molecules; 2014 Jul; 19(7):10090-102. PubMed ID: 25014535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
    Miyamoto K; Miyake S; Yamamura T
    Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.